59 wasmore effective against the proliferation and self-renewal capacityof a subpopulation of GSCs in single and combined therapy with TMZ.At the molecular level, 59 significantly reduced theexpression of the SOX2, SOX9, and BM1 genes (key regulators of a subpopulationof glioma stem cells). The gene discussed is SOX9; the disease is central nervous system cancer.